Download Sample
Loading...
| A02266 | Pages: 196 | Aug 2020 | 15802 Views | | |
| Author(s) : Komal Urde , Onkar Sumant | Tables: 114 | Charts: 14 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Medical Simulation Market
Request Now !The global medical simulation market size was valued at $1,421.1 million in 2019, and is projected to reach $3,190.2 million by 2027, growing at a CAGR of 14.6% from 2020 to 2027.
Medical simulation is virtual duplication of in situ activities or phenomenon, representing functions and properties of a selective real abstract or process. It is used to train healthcare professionals using advanced healthcare technologies.
Get more information on this report : Request Sample Pages
Rise in use of simulation in healthcare;increase in deaths, owing to medical errors; and necessity to improve patient safety outcomes are some factors that boost the medical simulation market growth. Moreover, benefits such as training of complex as well as normal cases to professionals and technological advancements in the medical field further increases demand for medical simulation. However, high installation cost and lack of complete real situation restrains the medical simulation market growth.
Further, COVID-19 has an unprecedented impact on medical education worldwide, leading to cancellation of lectures, exams, clinical rotations, and ultimately temporary closure of medical schools.
In March 2020, the International Nursing Association of Clinical Simulation and Learning (INACSL) and the Society for Simulation in Healthcare (SSH) issued a statement on the 'use of virtual simulation as a replacement for clinical hours’ during the pandemic caused by COVID-19. The use of virtual simulation technologies is likely to be adopted during the pandemic to enhance and strengthen procedural and patient care skills. Further, increase in use of remote learning with the help of screen-based simulation, augmented reality/AR, mixed reality, blended and/or extended reality, and virtual reality/VR is expected to drive growth of the virtual medical simulation market.
The global medical simulation market is segmented on the basis of product & service, fidelity, end user, and region. On the basis of product & service, it is divided into model-based simulation, web-based simulation, and simulation training services. The model-based simulation segment is further classified into patient simulation, surgical simulation, and ultrasound simulation. Moreover, patient simulation is segmented into task trainers, manikin-based simulators, and standardized patient simulators. Surgical simulation is divided in laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, and others. In addition, the web-based simulation segment is classified into simulation software, performance-recording software, and virtual tutors. The simulation training services segment comprise vendor-based training services, custom consulting services, and educational society services. By product & service, the model-based segment generated maximum revenue in 2019, accounting $727.47 million in 2019. The web-based simulation segment is expected to witness highest CAGR of 15.2% during the forecast period.
Get more information on this report : Request Sample Pages
On the basis of fidelity, the medical simulation market is classified into low-fidelity, medium fidelity, and high-fidelity simulators. By fidelity, the low-fidelity simulators segment dominated the market in 2019 with $671.29 million. High-fidelity segment is expected to witness highest CAGR of 15.3% during the forecast period.
By end user, the medical simulation market is divided into academic institutions & research centers, hospitals & clinics, and military organizations. The hospitals segment dominated the market in 2019 with $761.41. The academic institutions segment is expected to witness highest CAGR of 15.3% during the forecast period.
Get more information on this report : Request Sample Pages
Region wise, the medical simulation market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest share in the global medical simulation market. Asia-Pacific is expected to witness highest growth rate throughout the forecast period. Increase in use of medical simulationto minimize medical errors and further increase technological advancements by companies are anticipated to drive the overall market growth.
The major players profiled in the report are Laerdal Medical AS, CAE, Inc., 3D Systems, Inc., Simulab Corporation, Simulaids, Inc., Limbs and Things, Ltd., Kyoto Kagaku Co. Ltd., Mentice AB, Surgical Science Sweden AB, and Gaumard Scientific Company, Inc.
Key Benefits For Stakeholders
Key Market Segments
By Product & Services
By Fidelity
By End User
By Region
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key forces shaping the global medical simulation market
3.3.Market share analysis for learning management software
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in use of virtual and augmented reality
3.4.1.2.Assured improvement in patient safety outcomes
3.4.1.3.Benefits of medical simulation
3.4.1.4.Technological advancements in medical field
3.4.1.5.Increase in demand for virtual training
3.4.2.Restraints
3.4.2.1.High cost for setting up simulators
3.4.2.2.Limitation to imitate a complete real situation
3.4.3.Opportunities
3.4.3.1.Lucrative opportunities in emerging markets
3.5.Impact of COVID-19 on Medical Simulation Market
CHAPTER 4:GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE
4.1.Overview
4.1.1.Market size and forecast
4.2.Model-based simulation
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Patient simulation
4.2.2.1.1.Market size and forecast
4.2.2.2.Surgical simulation
4.2.2.2.1.Market size and forecast
4.2.2.3.Ultrasound simulation
4.3.Web-based simulation
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type
4.4.Simulation training services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type
CHAPTER 5:GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY
5.1.Overview
5.1.1.Market size and forecast
5.2.High-fidelity
5.2.1.Market size and forecast, by region
5.3.Medium-fidelity
5.3.1.Market size and forecast, by region
5.4.Low-fidelity
5.4.1.Market size and forecast, by region
CHAPTER 6:GLOBAL MEDICAL SIMULATION MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Academic institutions
6.2.1.Market size and forecast, by region
6.3.Hospitals
6.3.1.Market size and forecast, by region
6.4.Military organizations
6.4.1.Market size and forecast, by region
CHAPTER 7:GLOBAL MEDICAL SIMULATION, BY REGION
7.1.Market size and forecast
7.2.North America
7.2.1.North America: market size and forecast, by country
7.2.1.1.U.S. medical simulation: market size and forecast
7.2.1.1.1.U.S. medical simulation: market size and forecast, by product & service
7.2.1.2.U.S. Market size and forecast, by type
7.2.1.2.1.Patient simulation
7.2.1.2.1.1.Market size and forecast
7.2.1.2.2.Manikin-based simulation
7.2.1.2.2.1.Market size and forecast
7.2.1.2.3.Surgical simulation
7.2.1.2.3.1.Market size and forecast
7.2.1.2.4.Ultrasound simulation
7.2.1.2.5.Web-based simulation
7.2.1.2.5.1.Market size and forecast, by type
7.2.1.2.6.Simulation training services
7.2.1.2.6.1.U.S. medical simulation: market size and forecast, by fidelity
7.2.1.2.7.U.S. medical simulation: market size and forecast, by end user
7.2.1.3.Canada medical simulation: market size and forecast
7.2.1.3.1.Canada medical simulation: market size and forecast, by product & service
7.2.1.3.2.Canada medical simulation: market size and forecast, by fidelity
7.2.1.3.3.Canada medical simulation: market size and forecast, by end user
7.2.1.4.Mexico medical simulation: Market Size and Forecast
7.2.1.4.1.Mexico medical simulation: market size and forecast, by product & service
7.2.1.4.2.Mexico medical simulation: market size and forecast, by fidelity
7.2.1.4.3.Mexico medical simulation: market size and forecast, by end user
7.2.2.North America: market size and forecast, by product & services
7.2.3.North America: market size and forecast, by fidelity
7.2.4.North America: market size and forecast, by end user
7.3.Europe
7.3.1.Europe: market size and forecast, by country
7.3.1.1.Germany medical simulation: Market Size and Forecast
7.3.1.1.1.Germany medical simulation: market size and forecast, by product & service
7.3.1.1.2.Germany medical simulation: market size and forecast, by fidelity
7.3.1.1.3.Germany medical simulation: market size and forecast, by end user
7.3.1.2.France medical simulation: Market Size and Forecast
7.3.1.2.1.France medical simulation: market size and forecast, by product & service
7.3.1.2.2.France medical simulation: market size and forecast, by fidelity
7.3.1.2.3.France medical simulation: market size and forecast, by end user
7.3.1.3.UK medical simulation: market size and forecast
7.3.1.3.1.UK medical simulation: market size and forecast, by product & service
7.3.1.3.2.UK medical simulation: market size and forecast, by fidelity
7.3.1.3.3.UK medical simulation: market size and forecast, by end user
7.3.1.4.Italy medical simulation: market size and forecast
7.3.1.4.1.Italy medical simulation: market size and forecast, by product & service
7.3.1.4.2.Italy medical simulation: market size and forecast, by fidelity
7.3.1.4.3.Italy medical simulation: market size and forecast, by end user
7.3.1.5.Spain medical simulation: market size and forecast
7.3.1.5.1.Spain medical simulation: market size and forecast, by product & service
7.3.1.5.2.Spain medical simulation: market size and forecast, by fidelity
7.3.1.5.3.Spain medical simulation: market size and forecast, by end user
7.3.1.6.Rest of Europe medical simulation: market size and forecast
7.3.1.6.1.Rest of Europe medical simulation: market size and forecast, by product & service
7.3.1.6.2.Rest of Europe medical simulation: market size and forecast, by fidelity
7.3.1.6.3.Rest of Europe medical simulation: market size and forecast, by end user
7.3.2.Europe: market size and forecast, by product & service
7.3.3.Europe: market size and forecast, by fidelity
7.3.4.Europe: market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Asia-Pacific: market size and forecast, by country
7.4.1.1.Japan medical simulation: Market Size and Forecast
7.4.1.1.1.Japan medical simulation: market size and forecast, by product & service
7.4.1.1.2.Japan medical simulation: market size and forecast, by fidelity
7.4.1.1.3.Japan medical simulation: market size and forecast, by end user
7.4.1.2.China medical simulation: market size and forecast
7.4.1.2.1.China medical simulation: market size and forecast, by product & service
7.4.1.2.2.China medical simulation: market size and forecast, by fidelity
7.4.1.2.3.China medical simulation: market size and forecast, by end user
7.4.1.3.India medical simulation: market size and forecast
7.4.1.3.1.India medical simulation: market size and forecast, by product & service
7.4.1.3.2.India medical simulation: market size and forecast, by fidelity
7.4.1.3.3.India medical simulation: market size and forecast, by end user
7.4.1.4.Australia medical simulation: market size and forecast
7.4.1.4.1.Australia medical simulation: market size and forecast, by product & service
7.4.1.4.2.Australia medical simulation: market size and forecast, by fidelity
7.4.1.4.3.Australia medical simulation: market size and forecast, by end user
7.4.1.5.Rest of Asia-Pacific medical simulation: market size and forecast
7.4.1.5.1.Rest of Asia-Pacific medical simulation: market size and forecast, by product & service
7.4.1.5.2.Rest of Asia-Pacific medical simulation: market size and forecast, by fidelity
7.4.1.5.3.Rest of Asia-Pacific medical simulation: market size and forecast, by end user
7.4.2.Asia-Pacific: market size and forecast, by product & service
7.4.3.Asia-Pacific: market size and forecast, by fidelity
7.4.4.Asia-Pacific: market size and forecast, by end user
7.5.LAMEA
7.5.1.LAMEA: market size and forecast, by country
7.5.1.1.Brazil medical simulation: market size and forecast
7.5.1.1.1.Brazil medical simulation: market size and forecast, by product & service
7.5.1.1.2.Brazil medical simulation: market size and forecast, by fidelity
7.5.1.1.3.Brazil medical simulation: market size and forecast, by end user
7.5.1.2.South Africa medical simulation: market size and forecast
7.5.1.2.1.South Africa medical simulation: market size and forecast, by product & service
7.5.1.2.2.South Africa medical simulation: market size and forecast, by fidelity
7.5.1.2.3.South Africa medical simulation: market size and forecast, by end user
7.5.1.3.Saudi Arabia medical simulation: market size and forecast
7.5.1.3.1.Saudi Arabia medical simulation: market size and forecast, by product & service
7.5.1.3.2.Saudi Arabia medical simulation: market size and forecast, by fidelity
7.5.1.3.3.Saudi Arabia medical simulation: market size and forecast, by end user
7.5.1.4.Rest of LAMEA medical simulation: market size and forecast
7.5.1.4.1.Rest of LAMEA medical simulation: market size and forecast, by product & service
7.5.1.4.2.Rest of LAMEA medical simulation: market size and forecast, by fidelity
7.5.1.4.3.Rest of LAMEA medical simulation: market size and forecast, by end user
7.5.2.LAMEA: market size and forecast, by product & service
7.5.3.LAMEA: market size and forecast, by fidelity
7.5.4.LAMEA: market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.3D SYSTEMS CORPORATION (SIMBIONIX)
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.CAE INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.GAUMARD SCIENTIFIC COMPANY
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Product portfolio
8.3.4.Key strategic moves and developments
8.4.KYOTO KAGAKU CO. LTD.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.LAERDAL MEDICAL AS
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Key strategic moves and developments
8.6.LIMBS AND THINGS LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Key strategic moves and developments
8.7.MENTICE AB
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Key strategic moves and developments
8.8.SIMULAB CORPORATION
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.9.SIMULAIDS INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Key strategic moves and developments
8.10.SURGICAL SCIENCE SWEDEN AB
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Business performance
8.10.4.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCTS & SERVICES, 2019–2027 ($MILLION)
TABLE 02.GLOBAL MODEL-BASED SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.GLOBAL PATIENT SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.GLOBAL SURGICAL SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 05.GLOBAL WEB-BASED MEDICAL SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.GLOBAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.GLOBAL MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 08.GLOBAL MEDICAL SIMULATION MARKET FOR HIGH FIDELITY, BY REGION, 2019–2027($MILLION)
TABLE 09.GLOBAL MEDICAL SIMULATION MARKET FOR MEDIUM-FIDELITY, BY REGION, 2019–2027($MILLION)
TABLE 10.GLOBAL MEDICAL SIMULATION MARKET FOR LOW-FIDELITY, BY REGION, 2019–2027($MILLION)
TABLE 11.GLOBAL MEDICAL SIMULATION MARKET, BY END USER 2019–2027 ($MILLION)
TABLE 12.GLOBAL MEDICAL SIMULATION MARKET FOR ACADEMCI INSTITUTIONS, BY REGION, 2019–2027($MILLION)
TABLE 13.GLOBAL MEDICAL SIMULATION MARKET FOR HOSPITALS, BY REGION, 2019–2027($MILLION)
TABLE 14.GLOBAL MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY REGION, 2019–2027($MILLION)
TABLE 15.MEDICAL SIMULATION MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 16.NORTH AMERICA MEDICAL SIMULATION MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 17.U.S. MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 18.U.S. MODEL-BASED SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.U.S. PATIENT SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 20.U.S. PATIENT SIMULATION MARKET, BY PATIENT TYPE, 2019–2027 ($MILLION)
TABLE 21.U.S. SURGICAL SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 22.U.S. ULTRASOUND SIMULATION MARKET, BY TYPE, 2019-2027($MILLION)
TABLE 23.U.S. WEB-BASED MEDICAL SIMULATION MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 24.U.S. SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 25.U.S. MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 26.U.S. MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 27.CANADA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 28.CANADA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 29.CANADA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 30.MEXICO MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 31.MEXICO MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 32.MEXICO MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 33.NORTH AMERICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 34.NORTH AMERICA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 35.NORTH AMERICA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 36.EUROPE MEDICAL SIMULATION MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 37.GERMANY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 38.GERMANY MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 39.GERMANY MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 40.FRANCE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 41.FRANCE MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 42.FRANCE MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 43.UK MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 44.UK MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 45.UK MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 46.ITALY MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 47.ITALY MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 48.ITALY MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 49.SPAIN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 50.SPAIN MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 51.SPAIN MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 52.REST OF EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 53.REST OF EUROPE MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 54.REST OF EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 55.EUROPE MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 56.EUROPE MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 57.EUROPE MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 58.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 59.JAPAN MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 60.JAPAN MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 61.JAPAN MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 62.CHINA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 63.CHINA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 64.CHINA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 65.INDIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 66.INDIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 67.INDIA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 68.AUSTRALIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 69.AUSTRALIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 70.AUSTRALIA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 74.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 75.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 76.ASIA-PACIFIC MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 77.LAMEA MEDICAL SIMULATION MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 78.BRAZIL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 79.BRAZIL MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 80.BRAZIL MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 81.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 82.SOUTH AFRICA MEDICAL SIMULATION MARKET REVENUE, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 83.SOUTH AFRICA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 84.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 85.SAUDI ARABIA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 86.SAUDI ARABIA MEDICAL SIMULATION MARKET REVENUE, BY END USER, 2019–2027 ($MILLION)
TABLE 87.REST OF LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 88.REST OF LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 89.REST OF LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 90.LAMEA MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 91.LAMEA MEDICAL SIMULATION MARKET, BY FIDELITY, 2019–2027 ($MILLION)
TABLE 92.LAMEA MEDICAL SIMULATION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 93.3D SYSTEMS: COMPANY SNAPSHOT
TABLE 94.3D SYSTEMS: OPERATING SEGMENTS
TABLE 95.3D SYSTEMS: PRODUCT PORTFOLIO
TABLE 96.CAE: COMPANY SNAPSHOT
TABLE 97.CAE: OPERATING SEGMENTS
TABLE 98.CAE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 99.GAUMARD: COMPANY SNAPSHOT
TABLE 100.GAUMARD: PRODUCT PORTFOLIO
TABLE 101.KYOTO KAGAKU: COMPANY SNAPSHOT
TABLE 102.KYOTO KAGAKU: OPERATING SEGMENTS
TABLE 103.KYOTO KAGAKU: PRODUCT PORTFOLIO
TABLE 104.LAERDAL: COMPANY SNAPSHOT
TABLE 105.LAERDAL: OPERATING SEGMENTS
TABLE 106.LIMBS & THINGS: COMPANY SNAPSHOT
TABLE 107.LIMBS & THINGS: OPERATING SEGMENTS
TABLE 108.MENTICE: COMPANY SNAPSHOT
TABLE 109.MENTICE: OPERATING SEGMENTS
TABLE 110.SIMULAB: COMPANY SNAPSHOT
TABLE 111.SIMULAB: OPERATING SEGMENTS
TABLE 112.SIMULAIDS: COMPANY SNAPSHOT
TABLE 113.SIMULAIDS: OPERATING SEGMENTS
TABLE 114.SURGICAL SCIENCE: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 01.GLOBAL MEDICAL SIMULATION MARKET SEGMENTATION
FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.HIGH THREAT OF NEW ENTRANTS
FIGURE 05.LOW THREAT OF SUBSTITUTION
FIGURE 06.HIGH COMPETITIVE RIVALRY
FIGURE 07.MARKET DYNAMICS FOR MEDICAL SIMULATION MARKET
FIGURE 08.3D SYSTEMS: NET SALES, 2017–2019 ($MILLION)
FIGURE 09.3D SYSTEMS: REVENUE SHARE, BY PRODUCT & SERVICES, 2019 (%)
FIGURE 10.3D SYSTEMS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 11.CAE: NET SALES, 2018–2020 ($MILLION)
FIGURE 12.CAE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 13.CAE: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 14.SURGICAL SCIENCE: NET SALES, 2017–2019 ($MILLION)
Medical simulation is virtual duplication of in situ activities or phenomenon, representing functions and properties of a selective real abstract or process. It is used to train healthcare professionals using advanced healthcare technologies.
According to the analyst perspective, the market is expected to grow in the future, owing to increase in mortality rates from medical errors in healthcare facilities including hospitals. Furthermore, benefits associated with medical simulation such as training healthcare professionals about normal and complex medical cases are expected to boost adoption of medical simulation devices. Integration of augmented and virtual reality in medical simulation provides healthcare professionals a real time experience, which boosts adoption of medical simulation based on virtual reality. Moreover, rise in demand for improved patient safety outcomes is expected to boost the market growth. Additionally, high set-up cost of simulation and other related costs are expected to impede the market growth.
Rise in use of simulation in healthcare; increase in deaths, owing to medical errors; and necessity to improve patient safety outcomes are some factors that boost the market growth. Moreover, benefits such as training of complex as well as normal cases to professionals and technological advancements in the medical field further increases demand for medical simulation. However, high installation cost and lack of complete real situation restrains the market growth.
A. The total value of Medical Simulation market was $1,412.1 million in 2019.
A. The forecast period in the report is from 2020-2027.
A. The market value of medical simulation market in 2020 was $1,228.49 million.
A. The base year calculated is 2019 in the report.
A. As per the key industry leaders, owing to increase in mortality rates from medical errors in healthcare facilities including hospitals. Furthermore, benefits associated with medical simulation such as training healthcare professionals about normal and complex medical cases are expected to boost adoption of medical simulation devices.
A. Increase in use of AR & VR based technology by the key players to develop advanced medical simulators in the market is expected to drive the market growth during the forecast period.
A. The growth % of the medical simulation market is 14.6%.
A. Model-based simulation segment holds the maximum market share.
Enterprise
License/PDF
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers